Substance Abuse

Papers
(The H4-Index of Substance Abuse is 23. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Understanding why Patients with Substance use Disorders Leave the Hospital against Medical Advice: A Qualitative Study150
Self-Isolation: A Significant Contributor to Cannabis use during the COVID-19 Pandemic102
Opioid Use Disorder and the COVID 19 Pandemic: A Call to Sustain Regulatory Easements and Further Expand Access to Treatment93
Article Commentary: COVID-19 and Persons with Substance use Disorders: Inequities and Mitigation Strategies90
Article Commentary: Stepped Care for Opioid use Disorder Train the Trainer (SCOUTT) Initiative: Expanding Access to Medication Treatment for Opioid use Disorder within Veterans Health Administration F72
Engaging an Unstably Housed Population with Low-Barrier Buprenorphine Treatment at a Syringe Services Program: Lessons Learned from Seattle, Washington41
Cannabis use in Adolescence and Risk of Psychosis: Are there Factors that Moderate this Relationship? A Systematic Review and Meta-Analysis39
Article Commentary: It Will End in Tiers: A Strategy to Include “Dabblers” in the Buprenorphine Workforce after the X-Waiver35
The Intersection of Intimate Partner Violence and Substance use among Women with Opioid use Disorder35
The Relationship between Patient-Centered Care and Outcomes in Specialist Drug and Alcohol Treatment: A Systematic Literature Review33
Acceptability of Technological Solutions for Overdose Monitoring: Perspectives of People who use Drugs33
Article Commentary: Recommendations for Integrating Peer Mentors in Hospital-Based Addiction Care32
Medication Treatment for Opioid use Disorder and Community Pharmacy: Expanding Care during a National Epidemic and Global Pandemic32
Identifying #Addiction Concerns on Twitter during the COVID-19 Pandemic: A Text Mining Analysis31
Motivations for Using Electronic Cigarettes in Young Adults: A Systematic Review31
Increasing Buprenorphine access for Veterans with Opioid use Disorder in Rural Clinics using Telemedicine31
Opioid Treatment Programs, Telemedicine and COVID-19: A Scoping Review29
Concerns that An Opioid Antidote Could “Make Things Worse”: Profiles of Risk Compensation Beliefs Using the Naloxone-Related Risk Compensation Beliefs (NaRRC-B) Scale29
COVID-19: A Catalyst for Change in Telehealth Service Delivery for Opioid use Disorder Management29
Racial Inequities in U.S. Naloxone Prescriptions29
Changes in Young Adult Substance use during COVID-19 as a Function of ACEs, Depression, Prior Substance use and Resilience27
Article Commentary: Dismantling Racism Against Black, Indigenous, and People of Color across the Substance use Continuum: A Position Statement of the Association for Multidisciplinary Education and Re24
Characterization of Substance use among Underrepresented Sexual and Gender Minority Participants in the Population Research in Identity and Disparities for Equality (PRIDE) Study24
0.029325008392334